IP Library › Granted Patent US 11,001,860
Granted Patent B2
US 11,001,860 · App. 15/575,470 · Granted May 11, 2021

Poxvirus-derived promoter, and vector comprising same

Inventors: Sujeong Kim (Seoul, KR); Minjung Kim (Seoul, KR); Hwanjun Choi (Seoul, KR)
Assignee: KOLON LIFE SCIENCE, INC.
C12N15/8636C12N15/63C12N15/863
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,001,860
App. No.
15/575,470
Granted
May 11, 2021
Kind
B2
Abstract

The present invention provides a poxvirus-derived promoter, a vector comprising the same, a method for expressing a transgene using the promoter, and use of the vector in the prevention or treatment of a disease. A promoter according to the present invention can be used for induction of strong expression of a transgene.

Claims (23)

1. A recombinant nucleic acid molecule consisting of two or three different polynucleotides selected from the group consisting of the polynucleotides of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3,

wherein the two or three polynucleotides are consecutively linked in 5′ to 3′ direction in a way that 3′-end of an immediate preceding polynucleotide is linked to 5′-end of a next polynucleotide.

2. The recombinant nucleic acid molecule according to claim 1 , consisting of:

the polynucleotide of SEQ ID NO: 1; and

one or two polynucleotides selected from the group consisting of the polynucleotides of SEQ ID NO: 2 and SEQ ID NO: 3.

3. The recombinant nucleic acid molecule according to claim 2 , wherein the one or two polynucleotides selected from the group consisting of the polynucleotides of SEQ ID NO: 2 and SEQ ID NO: 3 is/are linked to the 3′-end of the polynucleotide of SEQ ID NO: 1 in a 5′ to 3′ direction.

4. A recombinant nucleic acid construct consisting of (a) the recombinant nucleic acid molecule according to claim 2 and (b) a restriction enzyme recognition site at the 5′-end and/or 3′-end of the recombinant nucleic acid molecule.

5. The recombinant nucleic acid molecule according to claim 1 , comprising the nucleotide sequence of SEQ ID NO: 9 or SEQ ID NO: 10.

6. A recombinant nucleic acid construct consisting of (a) the recombinant nucleic acid molecule according to claim 1 and (b) a nucleotide encoding a target protein, so as to induce expression of the target protein-encoding nucleotide sequence in a host cell.

7. The recombinant nucleic acid construct according to claim 6 , wherein the host cell is a mammalian cell and the target protein is expressed in cytoplasm of the mammalian cell.

8. A vector comprising the recombinant nucleic acid molecule according to claim 1 .

9. The vector according to claim 8 , which is a virus.

10. The vector according to claim 9 , which is derived from a virus of a poxviridae.

11. The vector according to claim 10 , wherein the virus of the poxviridae is selected from the group consisting of the viruses of orthopoxvirus, avipoxvirus, parapoxvirus, capripoxvirus, and suipoxvirus genuses.

12. The vector according to claim 10 , wherein the poxvirus is vaccinia virus.

13. A vector comprising the recombinant nucleic acid construct according to claim 6 .

14. The vector according to claim 13 , wherein the target protein is a tumor antigen, an immune response-inducing factor, a tumor growth-inhibitory factor, an apoptosis-inducing factor, or a factor which can aid in enhancing an activity of a virus in a tumor tissue.

15. A host transformed with a vector comprising the recombinant nucleic acid molecule according to claim 1 .

16. The host according to claim 15 , which is a microorganism, a mammal, a mammalian cell, or a cell line derived from a mammal.

17. A vector comprising the recombinant nucleic acid molecule according to claim 5 .

18. A vector comprising the recombinant nucleic acid construct according to claim 4 .

19. A vector comprising the recombinant nucleic acid molecule according to claim 3 .

20. A vector comprising the recombinant nucleic acid molecule according to claim 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2017
From: KIM, SUJEONG; KIM, MINJUNG; CHOI, HWANJUN
To: KOLON LIFE SCIENCE, INC.
Reel/Frame 044178/0730 →
Priority Claims (1)
KR 10-2015-0076197 · May 29, 2015 · national
Continuity (1)
Related Publication 20180080048A1 · Mar 22, 2018